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doi:10.1016/j.jmii.2011.11.008Background: Allergic disorders are common, chronic conditions in pediatric populations. The
characteristic symptoms of allergic disorders mainly include bronchial asthma (BA), allergic
rhinitis (AR), and atopic dermatitis (AD), all of which may disturb sleep, leading to daytime inat-
tention, irritability, and hyperactivity, which are also components of attention-deficit/
hyperactivity disorder (ADHD). Conflicting data exist in the literature regarding the relationship
between ADHD and allergic disorders. The aim of this nationwide, population-based study is to
examine the prevalence and risk of developing ADHDamong allergic patients in a pediatric group.
Methods: Data from a total of 226,550 pediatric patients under 18 years of age were collected
from Taiwan’s National Health Insurance Research Database recorded from January 1 to
December 31, 2005 and analyzed. We calculated the prevalence of allergic diseases based on
various demographic variables, including ADHD. We also used multivariable logistic regression
to analyze the risk factors of ADHD.
Results: In 2005, the period prevalence rates of allergic disorders and ADHD in persons under the
age of 18 were 21.5% and 0.6%, respectively. Pediatric patients with allergic disorder(s) had
a substantially increased rate of developing ADHD (p < 0.001) in terms of period prevalence
and odds ratio (OR). This significance existed across various demographic groups regardless of
age, gender, location, or degree of urbanization of their residence. BA and AR, but not AD, wereu, Division of Immunology and Nephrology, Department of Pediatrics, Taichung Veterans General
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238 C.-S. Shyu et al.determined to be risk factors for ADHD. Co-morbidities of allergic disorders, including ARþAD,
ARþBA and ARþBAþAD, but not BAþAD, were also determined to increase the risk of ADHD.
Conclusion: Allergic disorders appear to increase the risk of ADHD in pediatric patients. Our
detailed analysis shows that the main contributing factor is AR. Co-morbidity with AD, BA, and
BAþAD in AR patients further increases the risk of ADHD.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Allergic disorders are the most common chronic conditions
in pediatric populations. The major disorders include
bronchial asthma (BA), allergic rhinitis (AR), and atopic
dermatitis (AD). Recent surveys (based on the question-
naire developed by the International Study of Asthma and
Allergies in Childhood) have revealed that the prevalence
rates of AR in Taipei and central Taiwan are as high as 43.6%
and 44.4%, respectively. The rates of BA are 7.1% and 8.2%
in these regions, respectively, and the rates of eczema are
4.1% and 8.8%, respectively.1,2
Attention-deficit/hyperactivity disorder (ADHD) is diag-
nosed according to the DSM-IV (Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition) criteria.3 The
estimated prevalence of ADHD in children is 4e12%.4 There
are several common symptoms that present both in allergic
disorders and ADHD, such as sleep disturbance and cogni-
tive dysfunction.5e7 However, previous reports have
revealed conflicting data regarding the association
between ADHD and allergic disorders.8
The National Health Insurance (NHI) system provides
a comprehensive, unified, and universal health insurance
program for almost every person in Taiwan. Approximately
98% of the population of Taiwan participates in NHI.9
Therefore, Taiwan’s NHI Research Database (NHIRD) is
one of the largest and most comprehensive nationwide
population-based databases currently available. The
objective of this nationwide, population-based study was to
investigate the prevalence and risk of developing ADHD
among children with allergic disorders.
Materials and methods
Database
NHIRD is maintained by the National Health Research Insti-
tutes. Our data set was comprised of medical claims for
1,000,000 persons who were randomly selected from NHIRD,
which represents about 4.3% of the total population in
Taiwan. All persons in the database are enrolled in the NHI
system. The data consisted of ambulatory care and inpatient
care files, including registration records and demographic
data of the insured. There were no statistically significant
differences in terms of age, sex, or healthcare costs between
the sample group and all enrollees.
Patients
We conducted this cohort study by collecting automated
utilization data on all pediatric patients who were 0e17years old on January 1, 2005 and continuously enrolled in
NHI between January 1 and December 31, 2005. Thus,
226,550 enrollees were included in this study.
The identified patients were divided into two groups:
the general population and those with common allergic
disorders, including BA, AR, and AD. The allergic group
consisted of all pediatric patients with at least one diag-
nosed case of BA, AR, or AD (codes 493.xx, 477.xx, and
691.xx in the International Classification of Diseases [ICD-
9], 9th revision, respectively) who were listed as having an
outpatient visit or hospitalization during 2005 (i.e.,
provider-diagnosed allergic disorder). The diagnosis of
ADHD was based on at least one hospital admission or at
least two out-patient department visits where the outcome
was a diagnosis of ADHD (code 314.xx in ICD-9). In order to
protect privacy, the identities of the patients, physicians,
and institutions were scrambled in accordance with the
personal electronic data protection regulations.10
Data analysis
Pairwise comparisons were conducted to determine differ-
ences in demographic characteristics, including age, sex,
area, and urbanicity, as well as co-morbidity with ADHD. As
previous NHIRD studies have shown,11,12 we classified
urbanicity into three groups: 1) the urban group implies
those living in the “city” based on the address recorded in
the database; 2) the suburban group includes those living in
the “Jeng(鎮)” according to their address; and 3) those with
addresses indicating “Xiang(鄉) were classified as living in
a rural area. These geographical areas were defined using
data from different branches of the NHI bureau in Taiwan, as
performed in previous studies.11,13 We used the c2test to
compare differences in the prevalence rates of ADHD
between patients with allergic disorders and those in the
general population according to age, sex, location, and
urbanicity. Finally, multivariable logistic regression was
used to determine the factors that affected the presenta-
tion of ADHD in patients with an allergic disorder in 2005. SAS
version 9.2 (SAS Institute, Cary, NC) was used to analyze the
data. In this study, the significance level was set at p< 0.05.
Results
Of the 1,000,000 randomly selected people who were
continuously enrolled in NHI in 2005, 226,550 (22.65%) were
0e17 years of age. The period prevalence of allergic
disorders in this population was 21.4% (n Z 48,457). The
number of BA cases was 14,858 (6.2% of total enrollees),
the number of AR cases was 34,960 (15.3%), and the number
of AD cases was 10,620 (4.7%). Pairwise comparisons of
AR is associated with ADHD 239patients with allergic disorders (n Z 48,457) and the
general population (n Z 178,093) were performed in order
to determine differences in demographic characteristics,
including age, sex, location, and urbanicity, as shown in
Table 1. Table 1 also shows that the period prevalence of
ADHD was 0.6% (n Z 1307). Allergic patients had a higher
prevalence of ADHD than the general population (0.9% vs.
0.5%, p < 0.001).
Table 2 shows the prevalence of ADHD in children.
Compared with the general population, children with
allergic disorders showed a higher prevalence of ADHD
regardless of age, sex, location, or urbanicity.
Table 3 shows the factors associated with the prevalence
of ADHD in patients with allergic disorders, based on the
results of the logistic regression analysis. Compared with
children <6 years old, children between 6e11 years of age
had a higher risk of developing ADHD (OR Z 2.10; 95%
CIZ 1.85e2.39), and the 12e17-year-old group had a lower
risk of developing ADHD (OR Z 0.62; 95% CI Z 0.51e0.74).
Males also had a higher risk of developing ADHD (ORZ 3.76;
95% CIZ 3.26e4.32). Regarding location as a risk factor for
ADHD, the only significant difference was a lower risk in
central Taiwan compared with eastern Taiwan (ORZ 0.61;
95% CI Z 0.41e0.89); northern and southern Taiwan
showed no difference in terms of the risk of developing
ADHD compared with the eastern region. Patients in urban
areas were at a higher risk of developing ADHD than
patients in rural areas (OR Z 1.58; 95% CI Z 1.37e1.82).
In comparison with the general population, allergic
patients showed an overall higher risk for developing ADHD
(OR Z 1.53; 95% CI Z 1.38e1.75). When considering indi-
vidual allergic disorders, AR and BA, but not AD, showedTable 1 Demographic characteristics of patients with allergic d
variable Total
(n Z 226550)
General popul
(n Z 17809
n (%) n (%)
Age(years old)
<6 74973 (33.1) 53277 (29.9)
6-11 81529 (36.0) 64322 (36.1)
12-17 70048 (30.9) 60494 (34.0)
Gender
Female 108314 (47.8) 87750 (49.3)
Male 118236 (52.2) 90343 (50.7)
Area
North 111616 (49.3) 86101 (48.4)
Middle 44600 (19.7) 35316 (19.8)
South 64907 (28.7) 52081 (29.2)
East 5427 (2.4) 4595 (2.6)
Urbanization
Urban 131663 (58.1) 102507 (57.6)
Suburban 32372 (14.3) 25613 (14.4)
Rural 62515 (27.6) 49973 (28.0)
ADHD
No 225243 (99.4) 177214 (99.5)
Yes 1307 (0.6) 879 (0.5)higher risks of being associated with ADHD (ORZ 1.71, 95%
CI Z 1.48e1.98; OR Z 1.38, 95% CI Z 1.02e1.86; and
OR Z 0.73, 95% CI Z 0.48e1.09, respectively). Co-
morbidities, including ARþBA, ARþAD, and ARþBAþAD,
showed increased risks of association with ADHD (ORZ 1.63,
95% CI Z 1.26e2.06; OR Z 2.14, 95% CI Z 1.37e3.35; and
OR Z 2.02, 95% CI Z 1.19e3.46, respectively). However,
ADþBA was not shown to be a significant risk factor for the
development of ADHD (ORZ 0.72, 95% CIZ 0.18e2.89).Discussion
To the best of our knowledge, this is the first study to use
population-based NHI data to investigate the prevalence of
ADHD in pediatric patients with allergic disorders. Because
the NHI program covers 98% of the Taiwanese population
and 91% of medical institutions, the NHIRD offers unique
and practical information that can be used to analyze the
relationship between allergic disorders and ADHD.
Previous studies show conflicting results regarding the
relationship between ADHD and allergic disorders in
adolescents.8 Two controlled studies reported increased
ADHD symptoms according to clinical analyses of children
with allergies.14,15 However, negative findings were repor-
ted in other clinical allergy studies.16,17 In a systemic
review published in 2010 about allergic disorders as risk
factors for the development of ADHD,18 the authors found
12 studies that reported a positive association between BA
and ADHD and six studies that reported a positive associa-
tion between AD and ADHD. However, in this review, the
authors commented that the methodologies of many ofisorders and general population
ation
3)
with Allergic disease
(n Z 48457)
p-value
for c2test
n (%)
21696 (44.8) <0.001
17207 (35.5)
9554 (19.7)
20564 (42.4) <0.001
27893 (57.6)
25515 (52.7) <0.001
9284 (19.2)
12826 (26.5)
832 (1.7)
29156 (60.2) <0.001
6759 (14.0)
12542 (25.9)
48029 (99.1) <0.001
428 (0.9)
Table 2 Prevalence of ADHD in children with allergic disorders and the general population
variable General population
(n Z 178093)
with Allergic disorders
(n Z 48457)
Odds
ratio
95% CI p-value
for c2test
n (%) n (%)
Age(years old)
<6 219 (0.4) 123 (0.6) 1.38 1.11 w 1.72 0.005
6-11 519 (0.8) 257 (1.5) 1.86 1.60 w 2.17 <0.001
12-17 141 (0.2) 48 (0.5) 2.16 1.56 w 3.00 <0.001
Gender
Female 182 (0.2) 69 (0.4) 1.62 1.23 w 2.14 <0.001
Male 697 (0.8) 359 (1.3) 1.68 1.48 w 1.91 <0.001
Area
North 532 (0.6) 278 (1.1) 1.77 1.53 w 2.05 <0.001
Middle 105 (0.3) 50 (0.5) 1.82 1.30 w 2.54 <0.001
South 220 (0.4) 91 (0.7) 1.68 1.32 w 2.15 <0.001
East 22 (0.5) 9 (1.1) 2.27 1.04 w 4.95 0.044
Urbanization
Urban 619 (0.6) 309 (1.1) 1.76 1.54 w 2.02 <0.001
Suburban 87 (0.3) 42 (0.6) 1.83 1.27 w 2.65 0.002
Rural 173 (0.4) 77 (0.6) 1.78 1.36 w 2.33 <0.001
Table 3 Logistic regression model of factors with preva-
lence of ADHD in pediatric allergic patients
variable Odds
ratio
95% CI p-value
Lower Upper
Age(years old)
<6 1.00 d d
6-11 2.10 1.85 2.39 <0.001
12-17 0.62 0.51 0.74 <0.001
Gender
Female 1.00 d d
Male 3.76 3.28 4.32 <0.001
Area
East 1.00 d d
North 1.12 0.78 1.61 0.528
Middle 0.61 0.41 0.89 0.011
South 0.81 0.56 1.17 0.265
Urbanization
Rural 1.00 d d
Urban 1.58 1.37 1.82 <0.001
Suburban 0.99 0.80 1.23 0.930
Allergic condition
no allergic disorders 1.00 d d
AR or BA or AD 1.56 1.38 1.75 <0.001
AR 1.71 1.48 1.98 <0.001
AD 0.73 0.48 1.09 0.124
BA 1.38 1.02 1.86 0.039
AR and AD 2.14 1.37 3.35 0.001
AR and BA 1.63 1.28 2.06 <0.001
AD and BA 0.72 0.18 2.89 0.639
AR and BA and AD 2.02 1.19 3.46 0.010
R-Square Z 0.0666.
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articles about asthma19e25 and four articles about AD26e29
that showed a positive relationship with ADHD. In our
study, we found that AD alone does not have positive
association with ADHD. ADþAR had a higher OR than AR
alone. However, ADþBA did not demonstrate a positive
association with ADHD. Among published reports, however,
none investigated co-morbidities as possible risk factors at
the same time. In this systemic review, there were only two
previous studies available that used the ICD system for the
diagnosis of ADHD and allergic disorders. The study by
Secnik et al reports a positive association between asthma
and ADHD,22 and the study by Schmitt et al reports a posi-
tive association between AD and ADHD.26 Neither study
mentions co-morbidity with asthma or AD.
Investigations examining allergic disorders in children
with ADHD also report conflicting results. Blank et al
reported increased rates of allergies among children with
ADHD.30 In contrast, another control-matched study
revealed no difference in the rates of allergies between
children with ADHD and controls.31 A large community study
followed 1037 children from the ages of 3e18 years, but no
associations between ADHD and allergic disorders were
found, either clinically or biologically.32 A recent study by
Brawley et al examined the prevalence of AR in 30 children
with ADHD. Among these children, 80% showed AR symp-
toms, 61% were positive for the skin prick test, and 100%
had a family history of allergies.33
Analysis of the large database used in this study revealed
associations between some allergies and ADHD. We
analyzed associations between BA, AR, AD, and combina-
tions of these conditions with ADHD. AR was found to be the
most important contributing factor for the development of
ADHD among the various allergies that were investigated.
AR carried a higher risk for the development of ADHD than
BA or AD. Co-morbid conditions with AR all showed a higher
risk for the development of ADHD. In our study, AD was not
AR is associated with ADHD 241identified as a risk factor for the development of ADHD. BA
demonstrated an increased risk, but when combined with
AD there was no increased risk of developing ADHD. Previ-
ously reported conflicting findings may be attributable to
the inclusion of all allergic disorders into a single group due
to the small size of the study population, which would
therefore prohibit more specific groupings of allergic
conditions. We were able to utilize a large research data-
base, so it was possible to analyze all combinations of
allergic disorders, as shown in Table 3. In previous reports,
co-morbid conditions were not analyzed.
Possible explanations for the association between AR and
ADHD in previous reports include shared symptoms, behav-
ioral complications related to annoying AR symptoms, and
AR-associated sleep disturbance that can lead to daytime
fatigue, inattention, and impulsivity.7,8,34 In the largest
cohort study ever conducted in Germany, AD was associated
with ADHD.26 However, the same researchers further inves-
tigated sleep disturbance as a possible confounding factor in
this cohort. They found that only those AD patients with
sleep disturbance were at a higher risk of developing
ADHD.27 Craig et al demonstrated that intranasal steroids
decrease nasal symptoms, sleep complaints, and daytime
somnolence.35 Regarding the direct effects of treatment on
patients with both AR and ADHD, a conference report pub-
lished in 2004 described a combination therapy of cetirizine
and a stimulant for treating ADHD that was superior to single-
drug therapies (cetirizine or the stimulant alone), in terms of
both nasal and ADHD symptoms scores.36
NHIRD only provides data on treatment prevalence rates
related to allergies and ADHD. The prevalence rates were
inevitably lower than those obtained by questionnaire or
physician surveys.1,2,4 We could not analyze each patient’s
allergy sensitization status, sleep condition, or family
history. Nevertheless, NHIRD covers almost the entire
population in Taiwan, so these data may be of value for
researchers and clinicians.
In conclusion, this study shows associations between
allergic disorders, especially AR, and ADHD. Further anal-
ysis of the AR groups, including an epidemiological study
and an investigation into the therapies that concurrently
target both disorders are needed. We recommend that
pediatricians, especially those with expertise in allergies,
be aware of the potential for ADHD in their allergic
patients. The clinical history of ADHD should be considered
when providing treatment. Better health education is also
needed. Our data provide evidence that may be used to
educate caregivers and increase awareness about symp-
toms related to allergies and ADHD.Acknowledgments
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